VLBBKPNZMPVCIJ-QJOLPZQDSA-N
C21H26F2N3O6P — CID 126736180
Data last refreshed: (MolForge compound catalog, from PubChem)
About VLBBKPNZMPVCIJ-QJOLPZQDSA-N
VLBBKPNZMPVCIJ-QJOLPZQDSA-N (PubChem CID 126736180) has the molecular formula C21H26F2N3O6P and a molecular weight of 485.42 g/mol. Its IUPAC name is 1-[(4aR,7aR)-7,7-difluoro-2-oxo-2-propan-2-yloxy-4,4a,6,7a-tetrahydrofuro[3,2-d][1,3,2]dioxaphosphinin-6-yl]-4-[(4-ethylphenyl)methylamino]pyrimidin-2-one.
Molecular Properties
| Compound Name | VLBBKPNZMPVCIJ-QJOLPZQDSA-N |
|---|---|
| PubChem CID | 126736180 |
| Molecular Formula | C21H26F2N3O6P |
| Molecular Weight | 485.42 g/mol |
| Exact Mass | 485.15 |
| IUPAC Name | 1-[(4aR,7aR)-7,7-difluoro-2-oxo-2-propan-2-yloxy-4,4a,6,7a-tetrahydrofuro[3,2-d][1,3,2]dioxaphosphinin-6-yl]-4-[(4-ethylphenyl)methylamino]pyrimidin-2-one |
| SMILES | CCc1ccc(CNc2ccn(C3O[C@@H]4COP(=O)(OC(C)C)O[C@H]4C3(F)F)c(=O)n2)cc1 |
| InChI | InChI=1S/C21H26F2N3O6P/c1-4-14-5-7-15(8-6-14)11-24-17-9-10-26(20(27)25-17)19-21(22,23)18-16(30-19)12-29-33(28,32-18)31-13(2)3/h5-10,13,16,18-19H,4,11-12H2,1-3H3,(H,24,25,27)/t16-,18-,19?,33?/m1/s1 |
| InChIKey | VLBBKPNZMPVCIJ-QJOLPZQDSA-N |
| XLogP | 3.90 |
| TPSA | 100.91 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 485.42 |
| LogP ≤ 5 | 3.90 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phosphor', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 126736180 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.